If the FTC doesn’t intervene, according to Horizon Therapeutics, the Amgen merger could finish sooner than expected.
KEY POINTS Horizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the…
Search
Have an existing account?
Sign In
